You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 30, 2025

Drug Price Trends for XERAC AC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for XERAC AC

Average Pharmacy Cost for XERAC AC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
XERAC AC 6.25% SOLUTION 00096-0709-60 0.15965 ML 2025-04-23
XERAC AC 6.25% SOLUTION 00096-0709-35 0.20075 ML 2025-04-23
XERAC AC 6.25% SOLUTION 00096-0709-60 0.15976 ML 2025-03-19
XERAC AC 6.25% SOLUTION 00096-0709-35 0.20064 ML 2025-03-19
XERAC AC 6.25% SOLUTION 00096-0709-60 0.16003 ML 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for XERAC AC

Overview of XERAC AC

XERAC AC, also known as aluminum chloride hexahydrate, is a prescription antiperspirant commonly used to treat hyperhidrosis, a condition characterized by excessive sweating. It is particularly effective for axillary hyperhidrosis, which affects the underarm area.

Market Size and Growth

The market for treatments targeting hyperhidrosis, including XERAC AC, is growing steadily. The axillary hyperhidrosis market in the US, for instance, was valued at $65.6 million in 2020 and is projected to grow at a CAGR of more than 15% during the period 2021-2025[1].

Key Drivers of Growth

Several factors drive the growth of the XERAC AC market:

  • Increasing Demand for Hyperhidrosis Treatments: The need for effective treatments for hyperhidrosis is on the rise, driven by growing awareness and diagnosis rates. Aluminum chloride hexahydrate, the active ingredient in XERAC AC, is one of the initial treatments for mild to moderate hyperhidrosis[4].
  • High Compliance and Lack of Generic Options: Patients show high compliance with prescribed treatments like XERAC AC, and the absence of generic options for all marketed products increases revenue. This trend is expected to continue, as the first generic entry is not anticipated until the end of the forecast period[1].

Market Segmentation

By Application

XERAC AC is primarily used in pharmaceutical and cosmetic applications. In the pharmaceutical sector, it is used to treat hyperhidrosis, while in cosmetics, it is found in deodorants and other personal care products. The pharmaceutical and cosmetics segment is expected to grow at the fastest CAGR of 6.2% during the forecast period[4].

By Geography

The demand for XERAC AC is global, but regional markets vary. North America, Europe, and the APAC region are significant markets, with each showing different growth rates and market dynamics. For example, the North American market is driven by high awareness and diagnosis rates of hyperhidrosis[4].

Price Analysis

Current Pricing

XERAC AC is available at various price points, depending on the retailer and any discounts or coupons used. On average, the retail price for XERAC AC can be around $18.21, but it can be obtained for as low as $12.01 with coupons and discounts[5].

Price Projections

Given the growing demand and lack of generic alternatives, the prices of XERAC AC are likely to remain stable or increase slightly over the forecast period. However, competition from other treatments and market dynamics could influence pricing strategies.

Competitive Landscape

The market for hyperhidrosis treatments is competitive, with several products available, including other antiperspirants and more invasive treatments like neuromuscular blockades. XERAC AC competes with other aluminum chloride hexahydrate products such as Drysol and Hypercare. The launch of new treatments, like Ecclock (sofpironium bromide) in Q4 2022, also impacts the competitive landscape[1].

Challenges and Barriers

Despite the growth potential, the market faces several challenges:

  • Limited Disease Awareness: Low awareness of hyperhidrosis as a treatable condition can limit diagnosis and treatment rates, affecting market growth[1].
  • COVID-19 Pandemic Impact: The pandemic reduced social pressures and fear of office visits, temporarily affecting the market size in 2020. However, the market has shown signs of recovery since late 2020 through 2021[1].

Pipeline and Future Trends

The future of the XERAC AC market is influenced by ongoing research and development in hyperhidrosis treatments. Emerging novel trends include the development of new topical and systemic treatments. The pipeline analysis indicates a focus on improving efficacy and reducing side effects, which could impact the market share of existing treatments like XERAC AC[1].

Key Takeaways

  • Growing Market: The axillary hyperhidrosis market, including XERAC AC, is projected to grow significantly.
  • High Compliance: Patients show high compliance with XERAC AC, contributing to its market success.
  • Lack of Generic Options: The absence of generic alternatives maintains revenue for branded products.
  • Competitive Landscape: The market is competitive, with various treatments available.
  • Challenges: Limited disease awareness and pandemic impacts are key challenges.

FAQs

What is the current market size of the axillary hyperhidrosis market in the US?

The axillary hyperhidrosis market in the US was valued at $65.6 million in 2020[1].

What is the projected growth rate of the axillary hyperhidrosis market?

The market is projected to grow at a CAGR of more than 15% during the period 2021-2025[1].

What are the primary applications of XERAC AC?

XERAC AC is primarily used in pharmaceutical and cosmetic applications to treat hyperhidrosis and as an ingredient in deodorants and other personal care products[4].

How does the lack of generic options impact the market?

The lack of generic options for all marketed products increases revenue for branded treatments like XERAC AC, as patients remain on prescribed treatments[1].

What are the main challenges facing the XERAC AC market?

Limited disease awareness and the impact of the COVID-19 pandemic are significant challenges affecting the market size and growth[1].

Sources

  1. GlobalData, Axillary Hyperhidrosis Market Size, Share & Trends Analysis and Forecast 2020-2030.
  2. Drugs.com, Xerac AC Prices, Coupons, Copay Cards & Patient Assistance.
  3. ASPE, Antimicrobial Drugs Market Returns Analysis.
  4. IndustryARC, Aluminum Chloride Hexahydrate Market Size, Share - IndustryARC.
  5. GoodRx, Xerac AC Prices, Coupons & Savings Tips - GoodRx.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.